Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Artiva Biotherapeutics, Inc. ARTV

Set alert

Price alert · ARTV

All alert types
4.19 USD 0.00 0.00%

At close · Nov 2

4.15 -0.04 -0.95%

After hours · Nov 2, 4:05 PM ET

Bid
4.17 × 2
Ask
4.19 × 2
4.15 Day range 4.22
2.96 52-week range 14.53
YTD
-2.33%
1 year
+0.48%
Open
4.21
Prev close
4.19
Mkt cap
204.85M
Vol
938.35K
Avg vol
628.91K
EPS
-3.23
P/E
0.00
Div yield
0.00%
More statistics
Low
4.15
High
4.22
Forward P/E
-3.18
Beta
0.00
Short ratio
20.47
Inst. own
89.07%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
11.60
200-d avg
11.88
1y target
21.25

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ARTV has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.64 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -1.3×
FY 2019: 0.0×FY 2020: -11.8×FY 2021: -2.9×FY 2022: -3.6×FY 2023: -10.1×FY 2024: -1.9×FY 2025: -1.3×
FY 2019 5y median -2.9× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 105×FY 2022: 42.8×FY 2023: 8.3×FY 2024: 978×FY 2025: 0.0×
FY 2019 5y median 42.8× FY 2025
P/B 1.0×
FY 2019: 0.0×FY 2020: -9.8×FY 2021: -2.4×FY 2022: -1.5×FY 2023: -1.7×FY 2024: 1.3×FY 2025: 1.0×
FY 2019 5y median -1.5× FY 2025
P/FCF -1.3×
FY 2019: 0.0×FY 2020: -15.3×FY 2021: -12.4×FY 2022: -3.7×FY 2023: -5.5×FY 2024: -4.4×FY 2025: -1.3×
FY 2019 5y median -4.4× FY 2025
EV/EBITDA -1.1×
FY 2019: 0.0×FY 2020: -10.7×FY 2021: -0.7×FY 2022: -2.2×FY 2023: -9.6×FY 2024: -3.9×FY 2025: -1.1×
FY 2019 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 25.9×FY 2022: 25.9×FY 2023: 7.2×FY 2024: 875×FY 2025: 0.0×
FY 2019 5y median 25.9× FY 2025
FCF Yield -75.7%
FY 2019: 0.0%FY 2020: -6.6%FY 2021: -8.1%FY 2022: -27.1%FY 2023: -18.1%FY 2024: -22.7%FY 2025: -75.7%
FY 2019 5y median -22.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2660.9%FY 2022: -1213.3%FY 2023: -91.6%FY 2024: -26805.6%FY 2025: 0.0%
FY 2019 5y median -1213.3% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -3587.7%FY 2022: -1184.1%FY 2023: -82.7%FY 2024: -23304.0%FY 2025: 0.0%
FY 2019 5y median -1184.1% FY 2025
ROE -76.3%
FY 2019: 0.0%FY 2020: 83.4%FY 2021: 80.8%FY 2022: 41.5%FY 2023: 17.1%FY 2024: -31.3%FY 2025: -76.3%
FY 2019 5y median 17.1% FY 2025
ROIC -74.9%
FY 2019: 0.0%FY 2020: -76.4%FY 2021: -35.3%FY 2022: -53.9%FY 2023: -31.8%FY 2024: -33.5%FY 2025: -74.9%
FY 2019 5y median -35.3% FY 2025
ROA -64.0%
FY 2019: 0.0%FY 2020: -61.5%FY 2021: -42.3%FY 2022: -43.9%FY 2023: -26.3%FY 2024: -27.9%FY 2025: -64.0%
FY 2019 5y median -42.3% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 146.3%FY 2023: 579.2%FY 2024: -99.3%FY 2025: -100.0%
FY 2019 FY 2025
Operating Income -34.7%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -191.6%FY 2022: -12.3%FY 2023: 48.7%FY 2024: -119.4%FY 2025: -34.7%
FY 2019 FY 2025
EPS (diluted) 34.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -300.0%FY 2022: 18.6%FY 2023: 64.2%FY 2024: -337.0%FY 2025: 34.0%
FY 2019 FY 2025
Free Cash Flow -42.5%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -23.2%FY 2022: -235.5%FY 2023: 11.3%FY 2024: -9.8%FY 2025: -42.5%
FY 2019 FY 2025

Financial Health

Current Ratio 8.6×
FY 2019: 2.1×FY 2020: 4.5×FY 2021: 8.4×FY 2022: 4.1×FY 2023: 6.5×FY 2024: 15.4×FY 2025: 8.6×
FY 2019 5y median 8.4× FY 2025
Quick Ratio 8.6×
FY 2019: 2.1×FY 2020: 4.5×FY 2021: 8.4×FY 2022: 4.1×FY 2023: 6.5×FY 2024: 15.4×FY 2025: 8.6×
FY 2019 5y median 8.4× FY 2025
Debt / Equity 0.1×
FY 2019: -2.0×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.1×FY 2023: -0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2019 5y median -0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2019: 0.0×FY 2020: 1.3×FY 2021: 2.2×FY 2022: 1.5×FY 2023: 1.4×FY 2024: 0.5×FY 2025: 0.2×
FY 2019 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: -91.8×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31